Business Wire

"Crypto Click Affiliate" – Brand New and Upcoming ASP Specialized in Cryptocurrency!We Provide Only Exceptional ICOs That Passed Our Strict Guidelines and Help Facilitate Fundraising for Technological Developments with Potential!

Del

Crypto Click Limited has now started general affiliate registration for our ICO/cryptocurrency ASP “Crypto Click Affiliate” from 10th of November 2017.

“Crypto Click Affiliate” - ICO/cryptocurrency related ASP
Official Website: https://crypto-click.com/europa-member

- Concept of Crypto Click Affiliate

Our offered products are limited to cryptocurrency related products and affiliate commission will be paid out in Bitcoin.

ICOs (Initial Coin Offering) are attracting massive attention in the cryptocurrency industry at the moment.

ICOs are a way for start-up companies to raise money by selling investors tokens in exchange for equity, similar to an IPO.

ICO are booming with massive growth in the overall cryptocurrency industry. To illustrate this, there was an ICO that raised 35mil USD within 30sec, which was a big news in the industry.
Therefore “Crypto Click Affiliate” - the ICO and Cryptocurrency ASP - is the most attractive ASP, which provides our affiliates to earn massive commission with ICO products.

- Why ICO?

The ICO structure is very similar to an IPO.
If the tokens issued in the ICO was 1 USD as the starting price (for corporate fundraising), its price could go up to 2 USD, 3 USD and more when listed (=capital gain for investors).
This is the same effect as people investing in attractive unlisted stocks, more funds come into more attractive ICOs.

- Our mission is to serve our trusted affiliate partners with only exceptional ICOs. We believe this enables the advancement of technology, growth, and economic progress through our specialized affiliation program.

The growing popularity of ICOs in the global blockchain industry is due to it being the newest way of corporate funding.
However, there are a number of incorrect information in circulation about ICOs.

Free flow of ICO information is not consistent, therefore purchaser can receive inaccurate and twisted information causing big misunderstanding of the white paper and the project itself.
ICO hosts providing accurate and detailed information for a deeper understanding of the project is the key to a successful fundraising.

Crypto Click Affiliate is here to provide the much needed true information to our affiliates.
We will provide scheduled marketing material like ICO team interviews and IR information constantly.
Only exceptional ICOs that passed our strict guidelines are going to be our partners for their fundraising.
We have already lined up a number of credible ICO partners, mainly from Europe, through our extensive global network.
Please note that 4 of those amazing ICO partners are already in preparation and will soon be ready for their pre-sales.
And there are more and more of incredible ICO partners coming our way!

- Why Crypto Click Affiliate?

1. Life time commission
You can receive your commission permanently with Crypto Click Affiliate, unlike other affiliate systems.

In a general affiliate set up, affiliates earn their commission only from their customer’s first product purchase.
In our affiliation program, our affiliates will receive commission on their customer’s every purchase without limitation.
The more the customers purchase, the bigger the commission, permanently.

2. High average spending per customer
We have data that shows average spending of a customer is around 2,630 USD.
Please remember that ICO customers are investors and their investment amount is increasing in speed with the hype of the ICO market.

3. 100% approval rate!
In general affiliation, ASP pays out commission only after advertisers approve sales of affiliates.
ASPs are therefore unable to pay out commissions to affiliates without having these approvals.
With this non-transparent system, advertisers have the power and could falsely adjust sales of affiliates.

At Crypto Click Affiliate, we are the only ones to review, confirm and approve affiliate sales and not the advertisers.
With our innovative affiliation system, we can prevent the unfortunate losses of affiliate’s efforts.

4. Speedy 1 day commission payout
Speedy 1 day commission payout is now possible with these steps;

1. We send customer’s purchase amount to our payment solution system
2. We manage customer’s information within our system
3. We review, confirm and approve all the affiliate sales
4. We payout commission to our affiliates first
5. Finally we payout the rest to our ICO partners

Please note that on the first month of operation of our program, we will run payouts in 2 week cycles.
By January 2018, we estimated to be able to provide you payouts within 1 day!

5. Hybrid commission program with affiliate commission & bounty
Crypto Click Affiliate introduces the new “Bounty Program” apart from the affiliate commissions.
Our affiliates can earn ICO tokens as a “bounty” reward, in exchange for media exposure on SNS, blogs and video-sharing sites.

We provide revenue share (affiliate commission) + media exposure commission (bounty) as a new hybrid style of an ASP.
Please refer to below for our base reward program (please note that commission details will be adjusted for each ICO);

1. SNS Bounty
Twitter – Earn bounty by retweeting official ICO tweets five times.
Facebook – Earn bounty by providing “likes” and shares of official ICO posts.

2. Blog/Article post Bounty
Earn bounty by posting an article of the ICO’s whitepaper and road map.

3. Movie upload Bounty
Earn bounty by uploading original movies about ICO products.

Our affiliates can earn commission just by media exposure without actual sales, which is great for affiliation beginners!
Use both of our attractive hybrid commission programs to maximize your earnings!
Hurry and join us on our brand new cryptocurrency affiliate program now!

“Crypto Click Affiliate”
Website: https://crypto-click.com/europa-member

- Crypto Click (Website: https://crypto-click.hk/europa-official)

Crypto Click is the operating company of Crypto Click Affiliate, our main business focus is to offer the best ICO/cryptocurrency affiliate program and the best solutions for ICO marketing, such as our ICO information curation service, blockchain installation support, and altcoin listing support at our partner’s exchange market.

For more information, please refer to our company website above.

Contact information

Inquiry for Media
For further information, please contact us
Crypto Click Limited
Alice Chan, +852 98799568
Public Relations
info@crypto-click.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Completes Resubmission to FDA for Proposed Trastuzumab Biosimilar18.6.2018 02:53Pressemelding

Celltrion (KRX:068270) has made a resubmission to the FDA (U.S. Food and Drug Administration) to obtain its marketing approval for CT-P6, a proposed mAb biosimilar to Herceptin® (trastuzumab). Celltrion submitted its abbreviated Biologics License Applications (aBLAs) for CT-P10 and CT-P6 to the FDA in April and May of last year, respectively. However, it received CRLs (complete response letters) from the FDA related to the warning letter issued by the FDA in January 2018, related to the manufacturing facility in Incheon, South Korea. Celltrion had completed the resubmission for the approval of CT-P10, a proposed biosimilar to Rituxan® (rituximab) last month. In accordance with FDA regulations, the approval procedure will be usually finalized within six months from the resubmission, so Celltrion expects the approval for the U.S. market of the two proposed biosimilars within this calendar year. FDA has notified Celltrion of its re-inspection schedule regarding regular audit results, and

CES Asia: Innovation at the Speed of 5G15.6.2018 14:59Pressemelding

CES Asia® 2018 wrapped today with the rapid pace of global innovation front and center over the show’s three day duration. The next stage of technology advancements were showcased across vehicle tech, robotics, artificial intelligence (AI), virtual and augmented reality, digital health and more. The event, 24 percent larger than last year in terms of footprint, cemented itself as the place to fully experience how the pace of technology is accelerating globally. CES Asia, the premier event for tech innovation in the Asian marketplace, will return to Shanghai, China, June 11-13, 2019. “5G and AI are igniting growth across the entire tech ecosystem changing the way we interact with technology and the world around us,” said Gary Shapiro, president and CEO, Consumer Technology Association (CTA)™. “It’s incredible to see technology refining and reinventing itself at such a fast pace. Just six months ago we were at CES with life-altering tech all around us. This week, I saw that technology re

bluebird bio Announces New Interim Data from Phase 1 (HGB-206) Study of LentiGlobin™ Gene Therapy in Patients with Severe Sickle Cell Disease at Annual Congress of the European Hematology Association15.6.2018 10:00Pressemelding

bluebird bio, Inc. (Nasdaq: BLUE) today announced new interim data from the ongoing HGB-206 Phase 1 multicenter clinical study of LentiGlobin investigational gene therapy in patients with severe sickle cell disease (SCD) will be presented in an oral presentation on Saturday, June 16 at the 23rd Congress of the European Hematology Association (EHA) by Julie Kanter, M.D., Medical University of South Carolina, Charleston, South Carolina. “The consistent production of increased amounts of anti-sickling HbAT87Q in the Group C patients reflects the substantial positive impact of the changes introduced with the amended HGB-206 study protocol and refined manufacturing process. All four Group C patients with greater than or equal to three months follow-up are making over 30 percent anti-sickling HbAT87Q. The first patient treated, now with six months of follow-up, is producing over 60 percent anti-sickling HbAT87Q with a normal total hemoglobin level of 14.2 g/dL,” said David Davidson, M.D., ch

bluebird bio Presents New Data from Northstar (HGB-204) and Northstar-2 (HGB-207) Studies of LentiGlobin™ Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia at Annual Congress of the European Hematology Association15.6.2018 10:00Pressemelding

bluebird bio, Inc. (Nasdaq: BLUE) announced that new data from the completed Phase 1/2 Northstar (HGB-204) study in adolescents and adults with transfusion-dependent β-thalassemia (TDT) and any genotype, and its ongoing, Phase 3 Northstar-2 (HGB-207) multicenter clinical study of LentiGlobin™ investigational gene therapy in patients with TDT and non-β0/β0 genotypes, will be presented in an oral session on June 16 at the 23rd Annual Congress of the European Hematology Association by Franco Locatelli, M.D., Ph.D., of the IRCCS Ospedale Pediatrico Bambino Gesù of Rome, Italy. “The maturing data from HGB-204 and HGB-207 suggest that one-time treatment with LentiGlobin may address the underlying genetic cause of TDT. With our refined manufacturing process, the majority of patients with TDT and non-β0/β0 genotypes are transfusion-free and producing total hemoglobin at normal or near-normal levels,” said David Davidson, M.D., chief medical officer, bluebird bio. “We are on track to submit a m

AGP Group Announces the Acquisition of Soliver NV in Belgium, Representing a Key Step towards Becoming the Premier Global Leader in Designing and Manufacturing High-Tech Automotive Glazing15.6.2018 09:00Pressemelding

AGP, a high-tech specialty glass designer and manufacturer, has announced today the acquisition of Soliver NV, a European automotive glazing manufacturer with over 65 years of solid product and brand reputation. Soliver offers high-quality tempered and laminated glazing for high-end automobiles, as well as windshield solutions for trucks. AGP’s glazing heritage started in Berlin, with the Mannheim family´s first glass company. After 100 years and a clear vision to become a leader in specialty glass, AGP’s core eGlass technologies have responded to the rising demand in electrification, connectivity, shared mobility and autonomous driving, acting as an enabler of future mobility trends. The integration of Soliver into the AGP Group will strengthen the AGP eGlass value proposition and will be a game changer in a fast-evolving industry. “We are very excited to build upon Soliver’s great experience and track-record to take high-tech glazing to the next level, enabling our customer’s product

Rivoli Group announces completion of its new international corporate strategy15.6.2018 07:00Pressemelding

Rivoli Group AG completes its comprehensive operational restructuring process and acts with a new presence in the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180615005085/en/ Rivoli Group Announces Completion of Its New International Corporate Strategy (Photo: Business Wire) The Swiss based Rivoli Group AG has now completed the comprehensive restructuring process as part of the international realignment of its corporate strategy. After an intensive evaluation of the situation, the available resources and existing market potential, the Chairman of the Board of Directors Mr. Mourad Malloul, the management team and an international advisory committee coordinated the strategy together. "This is the beginning of a crucial new chapter for the Rivoli Group," the President and CEO of Rivoli Group AG said. The measure aims to strengthen the competitive advantages within the company group, to adjust their service offerings